Business Standard

Apollo Hospitals rallies 5%, hits new record high on strong Q1 revenue

The consolidated revenue grew 31% QoQ and 73% YoY at Rs 3,760 crore

Apollo Hospitals has been investing big in infrastructure and bringing in advanced technologies such as Proton Therapy for cancer treatment, which has resulted in a higher debt
Premium

Apollo Hospitals has been investing big in infrastructure and bringing in advanced technologies such as Proton Therapy for cancer treatment, which has resulted in a higher debt

SI Reporter Mumbai
Shares of Apollo Hospitals Enterprises hit a new record high of Rs 4,264, ralling 5 per cent on the BSE in the intra-day trade on Monday, after the company reported a strong 31 per cent quarter on quarter (QoQ) growth in consolidated revenue at Rs 3,760 crore for the quarter ended June 2021 (Q1FY22). On a year-on-year (YoY) basis, consolidated revenues rose 73 per cent from Rs 2,172 crore.

The healthy revenue growth was mainly driven by hospital segment, which grew 26.2 per cent QoQ to Rs 1,941 crore, while revenue from the pharmacy distribution segment grew 35 per

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in